The findings suggest that disease-associated microbes can actively drive intestinal inflammation by reshaping host metabolism, suggesting new therapeutic possibilities to prevent or disrupt diseases like infectious diarrhea and colorectal cancer.

The findings suggest the gut microbiota — microorganisms that live in the intestines — could be a therapeutic target to prevent hospital-acquired lung infections.

One immune cell signaling molecule was increased in active versus inactive Crohn’s disease in both endoscopic and histologic activity assessments, suggesting it could serve as a potential noninvasive marker of disease activity.

The annual event supports vital programs and family resources at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Study findings suggest a new therapeutic approach for a rare digestive disorder, microvillus inclusion disease.

Over the course of his 50-year career, Clapham made fundamental contributions to the discovery and characterization of ion channels — proteins that allow charged particles (ions) to move across cell membranes.